3. Initiating and Withdrawing Medical Management

  1. James W. Wheless
  1. David T. Hsieh1 and
  2. Bhagwan Indur Moorjani2,3

Published Online: 1 NOV 2012

DOI: 10.1002/9781119998600.ch3

Epilepsy in Children and Adolescents

Epilepsy in Children and Adolescents

How to Cite

Hsieh, D. T. and Moorjani, B. I. (2012) Initiating and Withdrawing Medical Management, in Epilepsy in Children and Adolescents (ed J. W. Wheless), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119998600.ch3

Editor Information

  1. Department of Pediatric Neurology, University of Tennessee Health Science Center, Le Bonheur Comprehensive Epilepsy Program and Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN, USA

Author Information

  1. 1

    San Antonio Military Medical Center, Division of Child Neurology, Wilford Hall Medical Center, Lackland AFB, TX, USA

  2. 2

    Hope Neurologic Center, La Quinta, CA, USA

  3. 3

    JFK Memorial Hospital, Indio, CA, USA

Publication History

  1. Published Online: 1 NOV 2012
  2. Published Print: 23 NOV 2012

ISBN Information

Print ISBN: 9780470741238

Online ISBN: 9781119998600



  • antiepileptic drugs;
  • EEG;
  • epilepsy;
  • pediatric;
  • seizures


The fundamental questions regarding the medical management of children and adolescents with epilepsy are when and in which patients to initiate treatment with antiepileptic drugs, and when and in which patients to discontinue treatment. The principles that shape these decisions are discussed, to include a thorough understanding of the risks and benefits of each option, providing a foundation upon which to have a partnering interchange with the patient and their family. The individualized decision to initiate or to discontinue antiepileptic drug therapy for a patient is usually focused upon preventing the occurrences of epileptic seizures, but is ultimately centered around minimizing morbidity and mortality, and maximizing quality of life for both the patient and their family.